Antonio E. Terrelonge
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 3
- Clostridium difficile and Clostridium perfringens research 1
-
- Diabetes Treatment and Management 2
- Diabetes Management and Research 1
- Journals
- The Lancet HIV (3 papers)Science Translational Medicine (1 paper)Stroke (1 paper)JAMA Network Open (1 paper)Diabetes Care (1 paper)
- Partner nations
- United States
In The Last Decade
Antonio E. Terrelonge
10 papers receiving 777 citations
Peers
Comparison fields: 5 of 67
- Endocrinology, Diabetes and Metabolism 254
- Virology 63
- Infectious Diseases 177
- Internal Medicine 22
- Cardiology and Cardiovascular Medicine 137
Countries citing papers authored by Antonio E. Terrelonge
This map shows the geographic impact of Antonio E. Terrelonge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio E. Terrelonge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio E. Terrelonge more than expected).
Fields of papers citing papers by Antonio E. Terrelonge
This network shows the impact of papers produced by Antonio E. Terrelonge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio E. Terrelonge. The network helps show where Antonio E. Terrelonge may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 206 | |
| 2 | 2019 | 159 | |
| 3 | 2018 | 125 | |
| 4 | 2021 | 86 | |
| 5 | 2021 | 83 | |
| 6 | 2019 | 77 | |
| 7 | 2023 | 24 | |
| 8 | 2022 | 18 | |
| 9 | 2023 | 17 | |
| 10 | 2024 | 3 |
About Antonio E. Terrelonge
Antonio E. Terrelonge is a scholar working on Infectious Diseases, Endocrinology, Diabetes and Metabolism, Rheumatology, Nutrition and Dietetics and Immunology, having authored 10 papers that have together received 798 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (3 papers), Diabetes Treatment and Management (2 papers), Diabetes Management and Research (1 paper), Clostridium difficile and Clostridium perfringens research (1 paper), Antiplatelet Therapy and Cardiovascular Diseases (1 paper), Fatty Acid Research and Health (1 paper), Systemic Lupus Erythematosus Research (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (254 citations), Virology (63 citations), Infectious Diseases (177 citations), Internal Medicine (22 citations) and Cardiology and Cardiovascular Medicine (137 citations). Antonio E. Terrelonge has collaborated with scholars based in United States. Their work appears in journals such as The Lancet HIV, Science Translational Medicine, Stroke, JAMA Network Open and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.